Werewolf Therapeutics (HOWL) Earnings Date & Reports
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
HOWL is expected to report earnings to rise 2.15% to -40 cents per share on August 07
Q2'25
Est.
$-0.41
Q1'25
Missed
by $0.02
Q4'24
Missed
by $0.04
Q3'24
Beat
by $0.03
Q2'24
Missed
by $0.05
The last earnings report on April 08 showed earnings per share of -40 cents, missing the estimate of -37 cents. With 188.06K shares outstanding, the current market capitalization sits at 35.89M.